Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate
Open Access
- 8 October 2012
- journal article
- review article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 58 (3), 609-618
- https://doi.org/10.1016/j.jhep.2012.09.021
Abstract
No abstract availableFunding Information
- Università di Bologna
This publication has 74 references indexed in Scilit:
- Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference reportThe Lancet Oncology, 2012
- Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomasJournal of Hepatology, 2011
- Liver Transplantation for Recurrent Hepatocellular Carcinoma on Cirrhosis After Liver Resection: University of Bologna ExperienceAmerican Journal of Transplantation, 2008
- Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinomaLiver Transplantation, 2007
- Early-Stage Hepatocellular Carcinoma in Patients with Cirrhosis: Long-term Results of Percutaneous Image-guided Radiofrequency AblationRadiology, 2005
- Radiofrequency Ablation of Small Hepatocellular Carcinoma in Cirrhotic Patients Awaiting Liver TransplantationAnnals of Surgery, 2004
- The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An UpdateAnnals of Internal Medicine, 2003
- Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantationGut, 2002
- Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survivalJournal of Hepatology, 2001
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisThe New England Journal of Medicine, 1996